v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (14,981) $ (3,854)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, amortization and impairment 3,481 487
Stock-based compensation 9,956 2,311
Change in fair value of warrants (11,382) 3,191
Changes in operating assets and liabilities    
(Increase)/ decrease in trade receivables, net (1,294) 581
(Increase)/ decrease in prepaid expenses and other current assets 514 (1,587)
Increase/ (decrease) in trade payables (1,032) 710
Decrease in operating lease right of use assets 1,332 0
Increase in employees and payroll accruals 2,227 355
Decrease in operating lease liabilities (1,782) 0
Increase in accrued expenses and other current liabilities 2,872 852
Net cash (used in)/ provided by operating activities (10,089) 3,046
Cash flows from investing activities:    
Acquisition of business, net of cash acquired (99,568) 0
Internal use software capitalization (6,975) (1,049)
Purchase of property and equipment (282) (378)
Founders' note receivable 0 (459)
Decrease (increase) in deposits 38 (58)
Net cash used in investing activities (106,787) (1,944)
Cash flows from financing activities:    
Repayment of acquisition liability 0 (126)
Proceeds from loans 9,000 0
Repayment of loans 0 (3,033)
Payment of SPAC merger transaction costs (3,185) 0
Proceeds from exercise of options 817 882
Net cash (used in)/ provided by financing activities 6,632 (2,277)
Decrease in cash, cash equivalents and restricted cash (110,243) (1,175)
Cash, cash equivalents and restricted cash at the beginning of the period 157,158 16,092
Cash, cash equivalents and restricted cash at the end of the period 46,915 14,917
Supplemental disclosure of cash flows activities:    
Income taxes paid, net of tax refunds 727 216
Interest 371 189
Non-cash transactions    
Business combination consideration paid in stock 47,152 0
Accretion of preferred stock to redemption value 0 52,993
Deferred offering cost included in accrued liabilities 0 2,406
Reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets    
Cash and cash equivalents 46,509 14,472
Long-term restricted deposits 406 445
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows $ 46,915 $ 14,917

Source